Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2007081995) UROTENSIN II RECEPTOR ANTAGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2007/081995 International Application No.: PCT/US2007/000644
Publication Date: 19.07.2007 International Filing Date: 10.01.2007
IPC:
A61K 31/535 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
535
having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
Applicants:
MARYANOFF, Bruce E. [US/US]; US (UsOnly)
KINNEY, William A. [US/US]; US (UsOnly)
LAWSON, Edward C. [US/US]; US (UsOnly)
LUCI, Diane K. [US/US]; US (UsOnly)
MARCHENKO, Nikolay [RU/RU]; RU (UsOnly)
SVIRIDOV, Sergey [RU/RU]; RU (UsOnly)
JANSSEN PHARMACEUTICA, N.V. [BE/BE]; Turnhoutseweg 30 B-2340 Beerse, BE (AllExceptUS)
Inventors:
MARYANOFF, Bruce E.; US
KINNEY, William A.; US
LAWSON, Edward C.; US
LUCI, Diane K.; US
MARCHENKO, Nikolay; RU
SVIRIDOV, Sergey; RU
SHYAMALI, Ghosh; US
Agent:
STERCHO, Yuriy P.; 145 King Of Prussia Road Radnor, Pennsylvania 19087, US
Priority Data:
60/757,69210.01.2006US
Title (EN) UROTENSIN II RECEPTOR ANTAGONISTS
(FR) ANTAGONISTES DU RÉCEPTEUR DE L'UROTENSINE II
Abstract:
(EN) The invention is directed to Urotensin II antagonists. More specifically, the present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and methods for treating Urotensin-II mediated disorders. Pharmaceutical and veterinary compositions and methods of treating cardiovascular disorders and various other disease states or conditions using compounds of the invention are also described.
(FR) L'invention concerne des antagonistes de l'urotensine II. Plus spécifiquement, la présente invention concerne certains nouveaux composés, des procédés de préparation de composés, de compositions, d'intermédiaires et de dérivés de ceux-ci, ainsi que des procédés de traitement de troubles médiés par l'urotensine II. La présente invention concerne également des compositions pharmaceutiques et vétérinaires ainsi que des procédés de traitement de troubles cardiovasculaires et de divers autres états ou conditions pathologiques en utilisant les composés de l'invention.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)